(PGX) |
| 0 (0%) 10-10 16:19 |
| Open: | |
| High: | |
| Low: | |
| Volume: | 0 |
| Market Cap: | 0(M) |
| PE Ratio: | 0 |
| Exchange: | |
| Industry: | |
| Sector: |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 11.92 |
| Resistance 1: | 11.76 |
| Pivot price: | 11.67 |
| Support 1: | 11.51 |
| Support 2: | 9.57 |
| 52w High: | |
| 52w Low: |
Financials
| EPS | 0.000 |
| Book Value | 0.000 |
| PEG Ratio | 0.00 |
| Gross Profit | 0.000 |
| Profit Margin (%) | 0.00 |
| Operating Margin (%) | 0.00 |
| Return on Assets (ttm) | 0.0 |
| Return on Equity (ttm) | 0.0 |
Company news
Fri, 12 Sep 2025
Quest Diagnostics Revamps PGx Offering Around Narrower Panel, Streamlined Results Reporting - 360Dx
Mon, 08 Sep 2025
Comparative evaluation of Oxford Nanopore Technologies’ adaptive sampling and the Twist long-read PGx panel for pharmacogenomic profiling - Frontiers
Thu, 04 Sep 2025
Quest Diagnostics Launches Advanced Pharmacogenomics (PGx) Offering - PR Newswire
Fri, 29 Aug 2025
Dr. Rona Relova’s FastTrack PGx Wins Prestigious Innovation Awards | VA Palo Alto health care | Veterans Affairs - VA.gov Home | Veterans Affairs
Sat, 26 Jul 2025
Benchmarking large language models for replication of guideline-based PGx recommendations - Nature
Wed, 16 Jul 2025
Sanford Imagenetics reaches PGx testing milestone - Sanford Health News
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
